Colfosceril palmitate
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
2,3-di(hexadecanoyloxy)propyl 2-trimethylazaniumylethyl phosphate | |
| Clinical data | |
| Trade names | Exosurf |
| AHFS/Drugs.com | International Drug Names |
| Identifiers | |
| CAS Number |
63-89-8 |
| ATC code | R07AA01 (WHO) |
| PubChem | CID 6138 |
| ChemSpider |
5908 |
| UNII |
319X2NFW0A |
| KEGG |
D03585 |
| ChEMBL |
CHEMBL1200737 |
| Synonyms | [2-({[2,3-bis(hexadecanoyloxy)propyl] phosphonato}oxy)ethyl]trimethylazanium |
| Chemical data | |
| Formula | C40H80NO8P |
| Molar mass | 734.039 g/mol |
| |
| |
| | |
Colfosceril palmitate (trade name Exosurf) is a drug used as a pulmonary surfactant.[1] It is a drug that is used in surfactant deficient conditions such as IRDS in newborns.
See also
References
- ↑ Rubin, B. K. (1996). "Therapeutic aerosols and airway secretions". Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine 9 (1): 123–130. doi:10.1089/jam.1996.9.123. PMID 10160202.
| ||||||||||||||||||
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
